A pilot, randomized, open-label, parallel study to compare the glycaemic variability of Type 2 diabetic patients on Dapagliflozin and Saxagliptin during Ramadan fasting
Latest Information Update: 19 Apr 2017
At a glance
- Drugs Dapagliflozin (Primary) ; Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Apr 2017 New trial record
- 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society